DNAprint Genomics (DNAG)

[dr frudaky]

jever00




That interview was very pedestrian in content and cosmetic in presentation. The projected markets for genealogy and forensics were admittedly limited and, IMHO, inconsequential for significant future revenues. The personalized medicine initiatives are too nascent for palpable predictions. The company is still living on faith and hope, as are the long suffering investors.

Bottom line: Significant recurring revenue deal in predictive medicine or the company will either just scrape by doing contract analyses services while continuing to dilute shareholder value to pay its employees or go out of business.

JMHO

dr f